Related Experiment Video
Updated: May 15, 2026
06:26
Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis
Published on: July 28, 2023
Systems approach to tuberculosis vaccine development.
Charles C Wang1, Bingdong Zhu, Xionglin Fan
1Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.
Respirology (Carlton, Vic.)
|January 22, 2013
Summary
Developing new tuberculosis vaccines is crucial due to the current vaccine
Area of Science:
- Immunology
- Vaccinology
- Infectious Diseases
Background:
- Tuberculosis (TB) remains a global health challenge with limited vaccine efficacy.
- The current bacillus Calmette-Guérin (BCG) vaccine offers inconsistent protection against adult pulmonary TB.
- Decades of research are yielding promising new TB vaccine candidates in clinical trials.
Purpose of the Study:
- To review advancements in tuberculosis vaccine development.
- To highlight new latency antigens and next-generation vaccine candidates.
- To discuss the role of systems biology and vaccinomics in accelerating vaccine research.
Main Methods:
- Review of current literature on tuberculosis vaccine development.
- Analysis of new discoveries in TB antigens and vaccine technologies.
- Exploration of systems biology and vaccinomics approaches.
Main Results:
- Several novel TB vaccine candidates are progressing through clinical trials.
- New insights into latency antigens offer potential for improved vaccine design.
- Systems biology and vaccinomics show promise for efficient vaccine development.
Conclusions:
- Overcoming TB requires innovative vaccine strategies beyond current BCG limitations.
- Understanding host-pathogen interactions and identifying reliable biomarkers are critical.
- Advanced technologies like systems biology and vaccinomics can expedite the creation of effective TB vaccines.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...